Financhill
Back

FibroGen Stock Predictions

FibroGen Stock Forecast

  • Is FibroGen Stock Undervalued?
    The current FibroGen [FGEN] share price is $0.38. The Score for FGEN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • FGEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will FibroGen Stock Go Up Next Year?

Data Unavailable

FibroGen Stock Rating

Data Unavailable

FibroGen Stock Price History

Is FGEN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FGEN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
fibrogen.com

52-Week Data

52-Week High:
2.93
52-Week Low:
0.29

Prediction Charts

Market Cap:
38.51M
Price in USD:
0.38
Volume:
3.33M
Beta:
1.04

Technical Analysis

SMA50:
0.37
SMA100:
0.55
SMA200:
1.08
52-Wk Change:
0.92%

Stock Predictions

  • Is FibroGen stock public?
    Yes, FibroGen is a publicly traded company.
  • What is the FibroGen stock quote today?
    The FibroGen stock price is 0.38 USD today.
  • How to buy FibroGen stock online?
    You can buy FibroGen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-24 0.33 0.32 0.34 0.32
Oct-25 0.32 0.31 0.34 0.30
Oct-28 0.31 0.30 0.33 0.30
Oct-29 0.31 0.30 0.31 0.30
Oct-30 0.31 0.31 0.33 0.30
Oct-31 0.31 0.30 0.32 0.29
Nov-1 0.30 0.32 0.34 0.30
Nov-4 0.32 0.32 0.33 0.32
Nov-5 0.33 0.31 0.33 0.30
Nov-6 0.30 0.31 0.32 0.30
Nov-7 0.31 0.31 0.33 0.30
Nov-8 0.31 0.32 0.33 0.31
Nov-11 0.32 0.34 0.36 0.32
Nov-12 0.34 0.38 0.40 0.33

FibroGen Earnings

Data Unavailable

FibroGen Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $0.65 per share.

* FibroGen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.